S. Nightingale

发表

Tuberculosis and HIV infection: A review

F. Bergmann, B. Ruf, D. Schürmann, 1997, Infection.

Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study

T. Solomon, D. Impoinvil, A. Rayamajhi, 2011, BMC infectious diseases.

Mental and cognitive healthcare training targeting primary healthcare workers providing HIV services in Africa: a scoping review

G. Sibeko, H. Gouse, J. Joska, 2022, AIDS care.

Measuring and managing cognitive impairment in HIV.

A. Winston, S. Nightingale, 2017, AIDS.

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia

C. Leen, M. Pirmohamed, L. Haddow, 2016, Journal of NeuroVirology.

Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder

K. Thomas, S. Safren, H. Gouse, 2022, Journal of NeuroVirology.

Controversies in HIV-associated neurocognitive disorders

A. Winston, S. Khoo, J. McArthur, 2014, The Lancet Neurology.

Cognitive Differences between Men and Women with HIV: A Systematic Review and Meta-Analysis.

K. Thomas, H. Gouse, J. Joska, 2021, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal

T. Solomon, L. Turtle, R. Kneen, 2015, PloS one.

A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal

T. Solomon, L. Turtle, B. Faragher, 2015, PloS one.

Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis

S. Anderson, R. Wilkinson, A. Arenivas, 2019, Wellcome open research.

Cognitive Impairment in Tuberculous Meningitis

R. Wilkinson, M. Solms, J. Joska, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

L. Dodd, G. Maartens, E. Meintjes, 2021, Wellcome open research.

069 Introduction of a simple lumbar puncture pack to a busy medical admissions unit improves diagnosis of central nervous system infections

T. Solomon, I. Hart, D. Cousins, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis

J. Farrar, M. Pirmohamed, A. Winston, 2016, Antimicrobial Agents and Chemotherapy.

Cognitive Performance, as well as Depression, Alcohol Use, and Gender, predict Anti-Retroviral Therapy Adherence in a South African Cohort of People with HIV and Comorbid Major Depressive Disorder

K. Thomas, S. Safren, H. Gouse, 2023, AIDS and Behavior.

Hiv-Associated Neurocognitive Disease: Case Studies and Suggestions for Diagnosis and Management in Different Patient Subgroups

A. Winston, A. Pozniak, H. Manji, 2014, Antiviral therapy.

Rates of cognitive impairment in a South African cohort of people with HIV: variation by definitional criteria and lack of association with neuroimaging biomarkers

R. Paul, K. Thomas, J. Heaps-Woodruff, 2021, Journal of NeuroVirology.

A review of the treatment of migraine.

S. Nightingale, 1984, Journal of clinical and hospital pharmacy.

THERAPEUTIC PROGRESS—REVIEW XIV

S. Nightingale, 1984 .

The posterior reversible encephalopathy syndrome in HIV infection

J. Ainsworth, S. Nightingale, C. Wood, 2012, BMJ Case Reports.

Four consecutive yearly point-prevalence studies in Wales indicate lack of improvement in sepsis care on the wards

Judith E. Hall, Noreen S. Syed, R. Ross, 2021, Scientific Reports.

The Use of Different Sepsis Risk Stratification Tools on the Wards and in Emergency Departments Uncovers Different Mortality Risks: Results of the Three Welsh National Multicenter Point-Prevalence Studies

Judith E. Hall, Noreen S. Syed, R. Lyons, 2021, Critical care explorations.

HIV-Associated CD8 Encephalitis: A UK Case Series and Review of Histopathologically Confirmed Cases

K. Wong, S. Lucas, Robert F Miller, 2021, Frontiers in Neurology.

HIV-Associated Neurocognitive Impairment Knowledge and Current Practices: A Survey of Frontline Healthcare Workers in South Africa

H. Gouse, J. Joska, S. Nightingale, 2020, Journal of Community Health.

Integrating HIV-Associated Neurocognitive Impairment Screening within Primary Healthcare Facilities: A Pilot Training Intervention

G. Sibeko, H. Gouse, J. Joska, 2022, Nursing research and practice.

Test them all; an easily diagnosed and readily treatable cause of dementia with life-threatening consequences if missed

S. Defres, T. Solomon, L. Benjamin, 2013, Practical Neurology.

CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF☆

C. Leen, M. Pirmohamed, L. Haddow, 2016, Cytokine.

Cognitive impairment in people living with HIV: consensus recommendations for a new approach

B. Ances, A. Winston, N. Nakasujja, 2023, Nature Reviews Neurology.

Exploring HIV-Associated Neurocognitive Impairment in the Era of Effective Antiretroviral Therapy: A Primary Healthcare Perspective

J. Joska, S. Nightingale, K. Sorsdahl, 2022, Qualitative health research.

Prevalence of HIV-1 Infection in an elderly rural population and associations with neurocognitive impairment.

C. D. de Jager, J. Joska, S. Nightingale, 2019, AIDS.

Moving on from HAND: why we need new criteria for cognitive impairment in people with HIV and a proposed way forward.

A. Winston, M. Gisslén, D. Saylor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.

A. Winston, M. Gisslén, J. Joska, 2021, AIDS.